Polymarket Eyes $20 Billion Valuation Following Rapid Revenue Growth and April Capital Raise
TL;DR — Polymarket is seeking a $20B valuation, up from $15B in spring after tripling annualized revenue to $1.2B. The April round included $600M from Intercontinental Exchange and $400M from D.E. Shaw and G Squared. Despite European bans and a South Carolina lawsuit, US prediction market daily volume hit $1.91B last month.
SCCG Take — This signals convergence of prediction markets with institutional finance, yet regulatory friction in Europe and the US requires client-partners to secure clearer guidance to protect momentum.
Leading prediction market operator Polymarket is allegedly seeking fresh capital at a $20 billion valuation. This represents a sharp increase from the company’s $15 billion valuation in spring.
The development comes from sources close to Bloomberg and was covered by GamblingNews. It follows an April funding round in which the company raised $1 billion, with the Intercontinental Exchange — owner of the New York Stock Exchange — committing $600 million. Hedge fund D.E. Shaw and venture capital firm G Squared supplied the remaining $400 million.
Just four months later, Polymarket is targeting the higher valuation despite being banned in many European countries over the past month. The company’s annualized revenue has tripled to $1.2 billion. At $20 billion, it would climb eight spots on CBInsights’ most valuable unicorns list, tying with Chobani and Perplexity. It would also exceed the market value of every US-listed sportsbook operator and every publicly traded US casino company except Las Vegas Sands.
Investor Confidence and Market Momentum
Investor appetite for prediction markets remains robust. Jefferies analyst Daniel Fannon noted that average daily volume across US prediction markets reached $1.91 billion last month. Major sports events such as the 2026 FIFA World Cup fueled growth, with competitor Kalshi adding more than 3 million new users during the championship.
The latest fundraising push underscores continued enthusiasm even as Polymarket conducts a phased rollout in the US. Backers appear to anticipate reduced reliance on sports derivatives over time, with hedging, institutional applications, and access to complex markets expected to expand the model’s reach.
Where the Risk Lies
A South Carolina lawyer has sued Polymarket, claiming it offers illegal gambling products in the state. This action reflects wider legal and regulatory disputes across the industry over sports event contracts.
The juxtaposition of surging valuations against bans in Europe and domestic litigation highlights a structural tension. For operators and investors, sustained capital inflows will likely depend on how these regulatory challenges resolve in the coming quarters.
Reporting: GamblingNews
Institutional money is flooding prediction markets faster than regulatory clarity can keep up — momentum and risk in equal measure.
We're watching capital markets collide with gambling regulation in real time. Polymarket's valuation leap — backed by NYSE's parent and top hedge funds — proves prediction markets are no longer fringe. But Europe's bans and US lawsuits show the regulatory path is anything but settled, and our clients need to move carefully.
- $20B target valuation, up from $15B in April; $1B raised from Intercontinental Exchange, D.E. Shaw, G Squared
- Annualized revenue tripled to $1.2B; US prediction market daily volume hit $1.91B last month
- European bans and South Carolina lawsuit underscore unresolved regulatory friction despite investor enthusiasm
SCCG angle: SCCG works with regulators, compliance advisors, and market-access partners across every regulated jurisdiction. When clients ask us about prediction market plays or derivative products, we connect them to the right legal, technical, and commercial resources to stress-test viability and navigate this fast-moving, high-stakes space without stepping on landmines.